Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-11-21Clinical Trial Update: A Study to Monitor the Safety of Enzalutamide in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy [Phase 2]
Phase 2 study updating safety observations of enzalutamide in men with progressive castration-resistant prostate cancer previously treated w…
-
CLINICAL_TRIALS trial_result · 2024-11-20Clinical Trial Update: A Study to Evaluate the Effect of Multiple Doses of Enzalutamide on the Pharmacokinetics of Substrates of P-glycoprotein (Digoxin) and Breast Cancer Resistant Protein (Rosuvastatin) in Male Subjects With Prostate Cancer [Phase 1]
This Phase 1 trial evaluated how multiple doses of enzalutamide affect the pharmacokinetics of digoxin and rosuvastatin, substrates of P-gly…
-
CLINICAL_TRIALS trial_result · 2024-11-20Clinical Trial Update: Comparison of MRI AI-cTB Versus Routine cTB in Prostate Cancer Diagnosis: a Prospective Randomized Controlled Trial [NA]
A completed randomized controlled trial comparing MRI AI-assisted cognitive targeted biopsy (MRI AI-cTB) to routine cognitive targeted biops…
-
CLINICAL_TRIALS trial_result · 2024-11-20Clinical Trial Update: Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC)
This is an observational cohort study update for castration-resistant prostate cancer, including metastatic cases, registered as NCT02380274…
-
CLINICAL_TRIALS trial_result · 2024-11-19Clinical Trial Update: A Study of Apalutamide (Adjuvant Treatment) and Androgen Deprivation Therapy (ADT) in Participants Who Have Undergone Radical Prostatectomy (RP) for Non-metastatic Prostate Cancer and Who Are at High Risk for Metastases [Phase 2]
Phase 2 trial evaluating adjuvant apalutamide with androgen deprivation therapy after radical prostatectomy in men with non-metastatic, high…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-11-19Clinical Trial Update: Pilot Cohort Study of Rb-82 Myocardial PET Imaging to Evaluate Coronary Microvascular Dysfunction in Men With Prostate Cancer Receiving Androgen-Deprivation Therapy
This clinical trial update reports a completed pilot cohort study using Rubidium-82 myocardial PET imaging to evaluate coronary microvascula…
-
CLINICAL_TRIALS trial_result · 2024-11-18Clinical Trial Update: Exercise as Medicine for People With Cancer Sweden [NA]
A Swedish trial by Karolinska Institutet evaluating exercise as medicine for cancer has completed; it includes prostate cancer, breast cance…
-
CLINICAL_TRIALS trial_result · 2024-11-15Clinical Trial Update: A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 study of Pegilodecakin (LY3500518) in patients with advanced solid tumors has completed, spanning multiple indications including mel…
-
CLINICAL_TRIALS trial_result · 2024-11-15Clinical Trial Update: PSMA-PET and MRI for Detection of Recurrent Prostate Cancer After Radical Treatment
This clinical trial update reports on the completed study evaluating PSMA-PET imaging and MRI for detecting recurrent prostate cancer after …
-
CLINICAL_TRIALS trial_result · 2024-11-15Clinical Trial Update: Combined PSMA PET/MRI for Detection of Lymph Node Metastases in High-risk Prostate Cancer Patients [NA]
Clinical trial update on a study using combined PSMA PET/MRI to detect lymph node metastases in high-risk prostate cancer patients. The stud…
-
CLINICAL_TRIALS trial_result · 2024-11-13Clinical Trial Update: Enzalutamide & Dutasteride/Finasteride as 1st Line Treatment for Patients =/> 65 Years Old With Prostate Cancer. [Phase 2]
Phase 2 study evaluating enzalutamide plus dutasteride or finasteride as first-line treatment for men aged 65 and older with prostate cancer…
-
CLINICAL_TRIALS trial_result · 2024-11-13Clinical Trial Update: Focal MR-Guided Focused Ultrasound Treatment of Localized Intermediate Risk Prostate Lesions [NA]
This clinical trial evaluated focal MR-guided focused ultrasound for localized intermediate-risk prostate cancer and has completed with resu…
-
CLINICAL_TRIALS trial_result · 2024-11-06Clinical Trial Update: Effectiveness of Open and Robotic Prostatectomy
A completed clinical trial evaluating the effectiveness of open versus robotic-assisted prostatectomy for prostate cancer.
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: A Prospective, Single-center, Single-arm, Pivotal Trial of the Medtronic Hugo™ Robotic Assisted Surgery (RAS) System
This is a prospective, single-center, single-arm pivotal trial evaluating the Medtronic Hugo Robotic Assisted Surgery System; enrollment is …
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: Prostate Cancer Survey
A completed clinical trial study related to prostate cancer conducted by the University of Maryland, Baltimore. The snippet does not provide…
-
CLINICAL_TRIALS trial_result · 2024-11-04Clinical Trial Update: Assessment of Research Digest Impact for Minority with Prostate Cancer, MiCAP Phase III Study [NA]
An update on the MiCAP Phase III trial evaluating the impact of a Research Digest for minority patients with prostate cancer; the study stat…
-
CLINICAL_TRIALS trial_result · 2024-11-04Clinical Trial Update: Suturing Techniques for Vesico-urethral Anastomosis [NA]
The document notes the completion of a clinical trial evaluating suturing techniques for vesico-urethral anastomosis in prostate cancer surg…
-
CLINICAL_TRIALS trial_result · 2024-11-01Clinical Trial Update: MR Fingerprinting for Diagnostic of Prostate Cancer
This update describes a completed clinical trial evaluating MR fingerprinting as a diagnostic approach for prostate cancer.
-
CLINICAL_TRIALS trial_result · 2024-11-01Clinical Trial Update: A Study to Observe Demography and the Outcome of Prostate Cancer Patients Treated With 6-month Triptorelin Formulation in Italy
A completed study evaluating the demographics and outcomes of prostate cancer patients in Italy treated with a 6-month formulation of tripto…
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: Study to Find Maintenance Dose for Periodic Administration of ASP3550 [Phase 2]
Phase 2 study evaluating a maintenance dose for periodic administration of ASP3550 in prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: A Study to Compare the Effect of ASP3550 With Goserelin in Patients With Prostate Cancer [Phase 3]
Phase 3 trial comparing ASP3550 with Goserelin in prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2024-10-30Clinical Trial Update: BioProtect Balloon Implant™ Balloon System Pivotal Study BP-007 [NA]
The pivotal BP-007 study of the BioProtect Balloon Implant Balloon System for prostate cancer has completed and posted results as of 2024-10…
-
CLINICAL_TRIALS trial_result · 2024-10-30Clinical Trial Update: A Study of PET/CT Imaging Using INR101 Injection in Healthy Male Subjects and Patients With Suspected Prostate Cancer [Phase 1, Phase 2]
The clinical trial evaluated INR101 Injection for PET/CT imaging in healthy male subjects and patients with suspected prostate cancer. The s…
-
CLINICAL_TRIALS trial_result · 2024-10-28Clinical Trial Update: A Study of LY3022855 In Participants With Breast or Prostate Cancer [Phase 1]
This Phase 1 study of LY3022855 in breast and prostate cancer has completed, with results posted on 2024-10-28.
-
CLINICAL_TRIALS trial_result · 2024-10-24Clinical Trial Update: PET Scan Study to Detect Prostate Cancer in Patients with Early PSA Recurrence [Phase 2]
A Phase 2 clinical trial is recruiting to evaluate PET imaging for detecting prostate cancer in patients with early PSA recurrence after pro…